Uptake of non-transferrin iron by erythroid cells

Anemia

Volumn 2011, Issue , 2011, Pages

  Prus, Eugenia ^a   Fibach, Eitan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952605576     PISSN: 20901267     EISSN: 20901275     Source Type: Journal    
DOI: 10.1155/2011/945289     Document Type: Article

References (33)

1. Richardson D. R., Ponka P., The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochimica et Biophysica Acta 1997 1331 1 1 40 2-s2.0-0031567095 10.1016/S0304-4157(96)00014-7 (Pubitemid 27168147)
2. Fleming M. D., Trenor C. C., Su M. A., Foernzler D., Beier D. R., Dietrich W. E., Andrews N. C., Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genetics 1997 16 4 383 386 2-s2.0-0030763856 (Pubitemid 27323306)
3. Cabantchik Z. I., Kakhlon OR., Epsztejn S., Zanninelli G., Breuer W., Intracellular and extracellular labile iron pools. Advances in Experimental Medicine and Biology 2003 509 55 75 2-s2.0-0041308118 (Pubitemid 37523738)
4. Cabantchik Z. I., Breuer W., Zanninelli G., Cianciulli P., LPI-labile plasma iron in iron overload. Best Practice and Research: Clinical Haematology 2005 18 2 277 287 2-s2.0-14544271816 10.1016/j.beha.2004.10.003 (Pubitemid 40298370)
5. Jacobs A., Low molecular weight intracellular iron transport compounds. Blood 1977 50 3 433 439 2-s2.0-0017700831 (Pubitemid 8180426)
6. Fibach E., Rachmilewitz E., The role of oxidative stress in hemolytic anemia. Current Molecular Medicine 2008 8 7 609 619 2-s2.0-59249091317 10.2174/156652408786241384
7. Prus E., Fibach E., The labile iron pool in human erythroid cells. British Journal of Haematology 2008 142 2 301 307 2-s2.0-47249094142 10.1111/j.1365-2141.2008.07192.x (Pubitemid 351987327)
8. Morgan E. H., Membrane transport of non-transferrin-bound iron by reticulocytes. Biochimica et Biophysica Acta 1988 943 3 428 439 2-s2.0-0023694365
9. Egyed A., Carrier mediated iron transport through erythroid cell membrane. British Journal of Haematology 1988 68 4 483 486 2-s2.0-0023938640
10. Garrick L. M., Dolan K. G., Romano M. A., Garrick M. D., Non-transferrin-bound iron uptake in Belgrade and normal rat erythroid cells. Journal of Cellular Physiology 1999 178 3 349 358 2-s2.0-0032947235 (Pubitemid 29070343)
11. Canonne-Hergaux F., Zhang AN. S., Ponka P., Gros P., Characterization of the iron transporter DMT1 (NRAMP/DCT) in red blood cells of normal and anemic mk/mk mice. Blood 2001 98 13 3823 3830 2-s2.0-0035895096 10.1182/blood.V98.13. 3823
12. Prus E., Fibach E., Flow cytometry measurement of the labile iron pool in human hematopoietic cells. Cytometry Part A 2008 73 1 22 27 2-s2.0-37849044860 10.1002/cyto.a.20491
13. Ramos P., Melchiori L., Gardenghi S., Van-Roijen N., Grady R. W., Ginzburg Y., Rivella S., str2010@med.cornell.edu Iron metabolism and ineffective erythropoiesis in β -thalassemia mouse models. Annals of the New York Academy of Sciences 2010 1202 24 30 10.1111/j.1749-6632.2010.05596.x
14. Fibach E., Manor D., Oppenheim A., Rachmilewitz E. A., Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989 73 1 100 103 2-s2.0-0024581574 (Pubitemid 19040960)
15. Fibach E., Prus E., Coligan J., Bierer B., Margulies D., Shevach E., Strober W., Differentiation of human erythroid cells in culture. Current Protocols in Immunology 2005 2, supplement 69 Edison, NJ, USA John Wiley & Sons 22.F7.1 22.F7.10
16. Weston S. A., Parish C. R., New fluorescent dyes for lymphocyte migration studies: analysis by flow cytometry and fluorescence microscopy. Journal of Immunological Methods 1990 133 1 87 97 2-s2.0-0025153163 10.1016/0022-1759(90) 90322-M (Pubitemid 20334488)
17. Weston S. A., Parish C. R., Calcein: a novel marker for lymphocytes which enter lymph nodes. Cytometry 1992 13 7 739 749 2-s2.0-0026666498 10.1002/cyto.990130710
18. Breuer W., Epsztejn S., Cabantchik Z. I., Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). Journal of Biological Chemistry 1995 270 41 24209 24215 2-s2.0-0028834446 10.1074/jbc.270.41.24209
19. Petrat F., Weisheit D., Lensen M., De Groot H., Sustmann R., Rauen U., Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor. Biochemical Journal 2002 362 1 137 147 2-s2.0-0037083893 10.1042/0264-6021:3620137 (Pubitemid 34174471)
20. Amer J., Goldfarb A., Fibach E., Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. European Journal of Haematology 2003 70 2 84 90 2-s2.0-0037331669 10.1034/j.1600-0609. 2003.00011.x (Pubitemid 36269554)
21. Bass D. A., Parce J. W., Dechatelet L. R., Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. Journal of Immunology 1983 130 4 1910 1917 (Pubitemid 13091657)
22. Loken M. R., Shah V. O., Dattilio K. L., Civin C. I., Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood 1987 69 1 255 263 2-s2.0-0023158748 (Pubitemid 17007105)
23. Kohgo Y., Ikuta K., Ohtake T., Torimoto Y., Kato J., Body iron metabolism and pathophysiology of iron overload. International Journal of Hematology 2008 88 1 7 15 2-s2.0-56749085451 10.1007/s12185-008-0120-5
24. Rivella S., Ineffective erythropoiesis and thalassemias. Current Opinion in Hematology 2009 16 3 187 194 2-s2.0-67749103803 10.1097/MOH.0b013e32832990a4
25. Kruszewski M., Labile iron pool: the main determinant of cellular response to oxidative stress. Mutation Research 2003 531 1-2 81 92 2-s2.0-0344154421 10.1016/j.mrfmmm.2003.08.004 (Pubitemid 37456724)
26. Prus E., Fibach E., Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells. Acta Haematologica 2009 123 1 14 20 2-s2.0-70449671208 10.1159/000258958
27. Rechavi G., Rivella S., Regulation of iron absorption in hemoglobinopathies. Current Molecular Medicine 2008 8 7 646 662 2-s2.0-59249095557 10.2174/156652408786241401
28. Prus E., Fibach E., Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells. Acta Haematologica 2009 123 1 14 20 2-s2.0-70449671208 10.1159/000258958
29. Zhang A. S., Canonne-Hergaux F., Gruenheid S., Gros P., Ponka P., Use of Nramp2-transfected Chinese hamster ovary cells and reticulocytes from mk/mk mice to study iron transport mechanisms. Experimental Hematology 2008 36 10 1227 1235 2-s2.0-52049099119 10.1016/j.exphem.2008.04.014
30. Leimberg J. M., Konijn A. M., Fibach E., Developing human erythroid cells grown in transferrin-free medium utilize iron originating from extracellular ferritin. American Journal of Hematology 2003 73 3 211 212 2-s2.0-0037969721 10.1002/ajh.10355 (Pubitemid 36753965)
31. Li H., Rybicki A. C., Suzuka S. M., Von Bonsdorff L., Breuer W., Hall C. B., Cabantchik Z. I., Bouhassira E. E., Fabry M. E., Ginzburg Y. Z., Transferrin therapy ameliorates disease in β -thalassemic mice. Nature Medicine 2010 16 2 177 182 2-s2.0-76349118307 10.1038/nm.2073
32. Leimberg J. M., Prus E., Link G., Fibach E., Konijn A. M., Iron-chelator complexes as iron sources for early developing human erythroid precursors. Translational Research 2008 151 2 88 96 2-s2.0-38049017900 10.1016/j.trsl.2007. 12.002
33. Kalantar-Zadeh K., Rodriguez R. A., Humphreys M. H., Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrology Dialysis Transplantation 2004 19 1 141 149 2-s2.0-0346656654 10.1093/ndt/gfg493 (Pubitemid 38072625)